莫西沙星治疗老年急性肺炎患者的临床疗效观察

目的：观察莫西沙星治疗老年急性肺炎患者的临床治疗效果。方法：将66例患者随机分成两组,应用莫西沙星治疗为治疗组,应用左氧氟沙星治疗为对照组。结果：治疗组治疗有效率、细菌清除率、不良反应发生率分别为90.91%、93.94%、9.09%,对照组治疗有效率、细菌清除率、不良反应发生率分别为78.79%、81.82%、12.12%,两组治疗有效率、细菌清除率分别比较,差异均有统计学意义（P〈0.05）,而不良反应发生率比较,差异无统计学意义（P〉0.05）。结论：莫西沙星是一种治疗老年急性肺炎安全、有效的药物。

Observation of clinical effect of Moxifloxacin in treatment of elderly patients with acute pneumonia

Objective：To observe the clinical effect of Moxifloxacin in treatment of elderly patients with acute pneumonia.Methods：66 patients were randomly divided into 2 groups,33 patients were treated with Moxifloxacin（treatment group） and 33 patients were treated with Levofloxacin（control group）.Results：The effective rate,bacterial clearing rate and occurrence of the adverse reaction for treatment group were 90.91%,93.94%,9.09% respectively and for control group were 78.79%,81.82%,12.12% respectively,the effective rate,bacterial clearing rate of two groups were compared,the differences were statistically significant（P〈0.05）,while the adverse reaction of two groups were compared,the difference was not significant（P〉0.05）.Conclusion：Moxifloxacin is a safe and effective medicine for treating elderly patients with acute pneumonia.